QSAM Biosciencesの機関の所有権
QSAM Biosciencesの機関の所有権は何ですか。
QSAM Biosciences, Inc.の機関の所有権は0.00%です。
機関の所有権の定義は何ですか。
機関所有権は、ミューチュアル・ファンドまたは年金基金、保険会社、投資会社、その他の資金を管理する他の団体が所有する会社の株式数です。
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
OTCのセクタHealth Careにおける機関の所有権の企業と比べるQSAM Biosciences
QSAM Biosciencesは何をしますか。
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
QSAM Biosciencesと類似の機関の所有権
- QSAM Biosciencesの機関の所有権は0.00%です。
- Rich Goldmanの機関の所有権は0.00%です。
- Multifield Internationalの機関の所有権は0.00%です。
- Solvay SAの機関の所有権は0.00%です。
- Monnet Ispat andの機関の所有権は0.00%です。
- Huali Universityの機関の所有権は0.00%です。
- Boyuan Constructionの機関の所有権は0.00%です。